Riskpilot← Back to searchSign inGet full accessIAROCA AB
ABActiveOrg 5592153794Redaregatan 48Research and experimental development on natural sciences and engineering · NACE 7210Est. 201912 employees
Revenue 2024
SEK 69K
+3350% vs 2023
EBITDA margin
-56501.4%
-77% vs 2023
Equity ratio
83.3%
Financial strength
Net profit 2024
SEK -39M
-73% vs 2023
| Revenue | SEK 69K | +3350% |
| EBITDA | SEK -39M | -77% |
| Net profit | SEK -39M | -73% |
| Total assets | SEK 66,8M | -4% |
| Equity | SEK 55,7M | +15% |
| Employees | 12 | — |
Legal name
IAROCA AB
Org number
5592153794
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
20 augusti 2019
Share capital
SEK 189 000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med Bourdette, Kasper Sven Gelberg, Jakob Gustav Peters, Filip Ludwig Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva forskning och utveckling inom hjärt- och kärlsjukdomar och därmed förenlig verksamhet.
Address
Redaregatan 48
Email
filip.peters@acorai.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 2 | 16 | 2 | 69 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −134 | −3 963 | −5 627 | −22 008 | −38 986 |
| Depreciation & amort. | −5 | −5 | −12 | −13 | −33 |
| EBIT | −139 | −3 968 | −5 639 | −22 021 | −39 019 |
| Net financials | — | −16 | −430 | −489 | 42 |
| Profit before tax | −139 | −3 984 | −6 069 | −22 511 | −38 977 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −139 | −3 984 | −6 069 | −22 511 | −38 977 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 303 | 8 878 | 18 695 | 69 783 | 66 826 |
| Equity | 301 | 2 217 | 12 285 | 48 233 | 55 673 |
| Long-term debt | 0 | 6 423 | 593 | 1 333 | 1 242 |
| Short-term debt | 2 | 238 | 5 817 | 20 218 | 9 911 |
| Total debt | 2 | 6 661 | 6 410 | 21 551 | 11 153 |
EBITDA margin
-56501.4%
This company
15.8%
Market median
-357704% vs market
20202024
Equity ratio
83.3%
This company
38.2%
Market median
+118% vs market
20202024
Return on equity
-70.0%
This company
18.4%
Market median
-480% vs market
20202024
Net profit margin
-56488.4%
This company
8.1%
Market median
-697488% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-08-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
FL Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
DA Chief Auditor | Chief Auditor | 2025 | — | — |
KM Audit | Audit | 2022 | — | — |
KS External Signatory | External Signatory | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Lumisonix Medical AB | Company | 68.0% | 68.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lumisonix Medical AB
IAROCA AB Board members of IAROCA AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Filip Ludwig Peters | Chief Executive Officer | 0 companies |
| Dan Andreas Johansson | Chief Auditor | 0 companies |
| Kim Martin Lavin | Audit | 0 companies |
| Kasper Sven Bourdette | External Signatory | 0 companies |
| Amir H Soltanianzadeh | Board of Directors | 0 companies |
| Kurt Michael Wandy Karlsson | Board of Directors | 0 companies |
| Jens Wilhelm Peters | Board of Directors | 0 companies |
| Jakob Gustav Gelberg | Board of Directors | 0 companies |
| Patrick N J Schnegelsberg | Chairman | 0 companies |
| Timothy Norris Irish | Board of Directors | 0 companies |